Mindsigns Health provides a cloud-based platform addressing neuropsychiatric illnesses like epilepsy and schizophrenia. By processing diverse data types, their system offers insights for treatment monitoring and symptom evolution, leading to better healthcare outcomes through timely interventions. The NeuroBrowser is currently being tested in Singapore’s healthcare system and a major US hospital, with the potential to reduce EEG analysis time by up to 75% in ICU and ambulatory settings. Their mobile product, GenMind, supports remote monitoring for cognitive impairments, enhanced by an ecological momentary assessment (EMA) pipeline aimed at improving patient functionality.